ABSTRACT
The global experience of health care financing systems, acquired as a result of the geoeconomic pandemic crisis of 2020-2022, requires a deep systemic retrospective study. It is substantiated that the SARS-CoV-2 coronavirus pandemic showed the weakness ofthe healthcare systems of the EU and Ukraine. However, it is advisable to consider it as a powerful multisystem trigger and catalyst for the transformation of healthcare sys-tems, the maximum impact of which is predicted in the financial and logistics sectors, which are considered the weakest link of local healthcare systems. It was determined that during the period of geo-economic pandemic instability, a fun-damental difference in ensuring the functioning of healthcare systems was clearly out-lined. The needfor a constructive redistribution of limited financial resources to combat the pandemic was combined with a global shortage of unique specialized resources. I n the process of analysis, the economic, epidemiological, and social effectiveness of the use ofthe Government Stringency Index (GSI), the Containment and Health Index (CHI) and Global Health Security Index (GHS) are emphasized. The study confirmed that during the period of geo-economic instability in the EU, the concept of global collective responsibility and increasing the sustainability of the health care financing system was conceptualized within the scope of the European Health Emergency Preparedness and Response Authority (HERA);EU4Health programs;single digital European health data space. The authors to introduce the concept of modification stability of health care financing systems, which is understood as process of transformation of the health care financing system, which make it possible to overcome unforeseeable variations of external and internal influences not with the aim of preventing their relapse, but with the prospect of stable recovery and self-improvement
ABSTRACT
Acute disseminated encephalomyelitis (AEM) and acute transverse myelitis (OPM) are autoimmune demyelinating diseases of the central nervous system. Two clinical observations of AEM and OPM developed after suffering acute coronavirus infection (SARS-CoV-2) are presented. Differential diagnosis was carried out with multiple sclerosis, encephalitis of an infectious nature, compressive myelopathy, and opticomyelitis. Both observations show an almost complete recovery of lost functions. The pathogenetic mechanisms of the development of AEM and OPM in patients with coronavirus infection are discussed. The onset of central nervous system dysimmune lesion in the context of coronavirus infection makes it necessary to monitor the clinical situation with the involvement of a neurologist for timely diagnosis and determination of therapeutic tactics that can reduce the degree of disability of patients.